Recommendations for biomarker-based diagnosis of neurocognitive disorders

Experts from 11 European scientific associations and organizations and a patient advocacy association (Alzheimer Europe) have collaborated to define a diagnostic pathway focused on each individual case that enables the right tests to be identified according to the symptoms profile.

Leave A Comment

Your email address will not be published. Required fields are marked *